Evidence map›Paper›PMID 41333544›Full record

ArticlePhysics and imaging in radiation oncology2025

A machine learning approach for radiation pneumonitis prediction in elderly esophageal cancer patients by integrating baseline computed tomography radiomics, dosiomics, and clinical characteristics.

Zhunhao Zheng, Junqiang Chen, Xiaolin Ge, Meng Yan, Ling Li, Qifeng Wang, Xiaomin Wang, Xin Wang, Wenyang Liu, Yonggang Shi and 6 more

Registry-linked trialAbstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02979691 (A Phase II/III Study Comparing Simultaneous Integrated Boost), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02979691 phase2 / phase3completednot on this map

A Phase II/III Study Comparing Simultaneous Integrated Boost (SIB) Intensity Modulated Radiation Therapy (IMRT) With S1 Based SIB-IMRT Followed by Adjuvant Chemotherapy With S1 in Elderly Patients With Esophageal or Esophagogastric Cancer (3JECROG-P01)

TypeinterventionalSponsorChinese Academy of Medical SciencesRan2016 to 2020Enrolled350ConditionsEsophagus Cancer, Esophagogastric Junction Cancer, Radiotherapy, ComplicationsArmsSIB-IMRT, S-1
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zhunhao ZhengDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Junqiang ChenDepartment of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xiaolin GeDepartment of Radiation Oncology, Jiangsu Province Hospital, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Meng YanDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Ling LiDepartment of Oncology, Tengzhou Central People's Hospital, Tengzhou, China.
Qifeng WangDepartment of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China.
Xiaomin WangDepartment of Radiation Oncology, Anyang Cancer Hospital, Anyang, China.
Xin WangDepartment of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wenyang LiuDepartment of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yonggang ShiDepartment of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaofeng WangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Hongyun ShiDepartment of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding, China.
Zhilong YuDepartment of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Qingsong PangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zefen XiaoDepartment of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wencheng ZhangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: To integrate clinical characteristics, radiomics, and dosiomics to provide accurate and individualized prediction of radiation pneumonitis (RP) in elderly patients aged 70 and over with esophageal cancer receiving radiotherapy. Materials and methods: Based on a phase III clinical study (NCT02979691) that included elderly patients with esophageal squamous cell carcinoma (ESCC) who received definitive radiotherapy, we selected a total of 229 patients with available computed tomography (CT) and dose images. Radiomic and dosiomics features were extracted from both lungs. The patients were randomly assigned to either the training group (N = 161) or the test group (N = 68) in a 7:3 ratio. In the training set, logistic regression (LR) was applied to calculate the radiomic score (R score) and dosiomic score (D score). The constructed multivariate LR and ridge regression prediction models were evaluated using the test set. The endpoint of the predictive model is defined as a grade ≥ 2 RP. Discrimination and prediction were assessed by calculating the area under curve (AUC) of the receiver operating characteristic curve and plotting calibration and decision curve analyses (DCA). Results: The hybrid LR model integrating R score, D score and clinical characteristics had the best clinical applicability. The hybrid model demonstrated superior predictive performance on the test set, achieving an area under the curve (AUC) of 0.76, while the combined clinical and DVH model achieved an AUC of 0.70. Conclusions: A hybrid model combining radiomics and dosiomics with clinical characteristics showed the best performance for predicting RP.

Indexed as

DosiomicsElderly patientsEsophageal cancerRadiation pneumoniaRadiomics

Identifiers

PMID41333544
PMCPMC12666797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.